Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Evaluation of 18F-DPA-714 PET-MRI imaging for locating epileptic focus in patients with drug-resistant partial epilepsy before surgery

    Recruiting

    1 1
    Investigated diseases:
    France
  • Study on the Safety and Effectiveness of Sirolimus and Vigabatrin for Preventing Symptoms in Infants with Tuberous Sclerosis Complex

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on the Effectiveness and Safety of Sirolimus for Patients with Drug-Resistant Epilepsy Linked to Tuberous Sclerosis Complex

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on the Effectiveness and Safety of Levetiracetam XR for Patients with Drug-Resistant Partial Onset Epilepsy

    Recruiting

    1 1 1
    Investigated drugs:
    Bulgaria Czechia Germany Greece Hungary Italy +3
  • Study on Cannabidiol and Dronabinol for Children with Refractory Epilepsy

    Recruiting

    1 1
    Investigated drugs:
    The Netherlands
  • Study on the Effectiveness and Safety of Perampanel for Children with Epilepsy

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Spain
  • Study on Clioquinol for Reducing Seizures in Patients with Drug-Resistant Epilepsy

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study on Cannabidiol for Reducing Seizures in Children and Young Adults with Severe Epilepsy Associated with Rare Diseases

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • [18F]CPFPX PET in Patients With Drug-Resistant Epilepsy and Healthy Subjects

    Not yet recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France
  • A study of TRV045 to test its effects on brain cell electrical activity in healthy adult men for epilepsy treatment development

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    The Netherlands